Clinical Trial: Microneedle Intra-Arterial Injection for Retinal Artery Occlusion

U.S., Sept. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07151755) titled 'Microneedle Intra-Arterial Injection for Retinal Artery Occlusion' on Aug. 25.

Brief Summary: This prospective interventional study evaluates the efficacy and safety of direct intra-arterial microneedle injection combined with pars plana vitrectomy for acute retinal artery occlusion (including central retinal artery occlusion [CRAO] and branch retinal artery occlusion [BRAO] involving the macula or causing severe visual loss). The primary endpoint is best-corrected visual acuity (BCVA, LogMAR) at 1 month. Secondary objectives include assessing the effect of treatment timing and monitoring longitudinal changes in visual function and ...